Elevation Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Buy
2,212
+987
+81% +$116K 0.09% 113
2026
Q1
$147K Buy
1,225
+29
+2% +$3.35K 0.05% 137
2025
Q4
$126K Buy
1,196
+65
+6% +$6.1K 0.04% 149
2025
Q3
$94.9K Sell
1,131
-159
-12% -$13.1K 0.03% 181
2025
Q2
$102K Sell
1,290
-269
-17% -$21.4K 0.04% 175
2025
Q1
$140K Buy
1,559
+4
+0.3% +$373 0.06% 134
2024
Q4
$155K Buy
1,555
+4
+0.3% +$412 0.07% 130
2024
Q3
$176K Buy
1,551
+3
+0.2% +$356 0.08% 124
2024
Q2
$192K Buy
1,548
+3
+0.2% +$386 0.09% 110
2024
Q1
$204K Sell
1,545
-173
-10% -$21.3K 0.1% 107
2023
Q4
$177K Buy
1,718
+730
+74% +$75.8K 0.11% 114
2023
Q3
$102K Buy
988
+3
+0.3% +$323 0.09% 92
2023
Q2
$114K Buy
985
+4
+0.4% +$454 0.1% 87
2023
Q1
$104K Buy
+981
New +$106K 0.1% 95

Other funds holding MRK

Elevation Wealth Partners's MRK Position: Q2 2026 in Review

Elevation Wealth Partners increased its Merck (MRK) stake by 81% in Q2 2026, buying an estimated $116K and bringing the position to 2,212 shares worth $284K. The position accounts for 0.09% of the portfolio, ranked #113.

Elevation Wealth Partners first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elevation Wealth Partners held 2,212 shares of Merck worth $284K as of Q2 2026.
  • Elevation Wealth Partners bought 987 Merck shares in Q2 2026, an estimated $116K.
  • Merck made up 0.09% of Elevation Wealth Partners's portfolio in Q2 2026, its #113 holding.
  • Elevation Wealth Partners first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.